Drug profile · INN
tizanidine hydrochloride
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride (TIZANIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — tizanidine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
tizanidine hydrochloride (TIZANIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tizanidine hydrochloride?
tizanidine hydrochloride (TIZANIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tizanidine hydrochloride?
TIZANIDINE HYDROCHLORIDE is a marketed brand name for tizanidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tizanidine hydrochloride?
tizanidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.